India, Jan. 27 -- This Small-cap Pharma Stock, engaged in providing integrated contract research, development, and manufacturing services for pharmaceuticals, biotech, nutrition, animal health, and speciality chemicals globally, hit a 10 percent lower circuit today and crashed up to 17.60 percent in the last 2 trading sessions. In this article, we will explore the reasons behind the decline in the stock's value.

With a market capitalization of Rs. 19,675.53 crores, the shares of Syngene International Limited hit a 10 percent lower circuit of Rs. 488.30 per share on Tuesday, down from its previous closing price of Rs. 542.55 per share. Since then, the stock has breached its lower circuit and is currently trading at Rs. 482.55 per equity s...